ChristopherWilleyMDPhD
Radiation Oncology • Birmingham, ALCentral Nervous System Cancer, Head & Neck, Thoracic Cancer
Professor and Associate Vice Chair of Translational Research, Department of Radiation Oncology, University of Alabama at Birmingham School of Medicine
Dr. Willey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1717 6th Ave S
Birmingham, AL 35233Phone+1 800-822-8816
Summary
- Dr. Christopher Willey is a radiation oncologist in Birmingham, AL and is affiliated with multiple hospitals in the area, including Birmingham Veterans Affairs Medical Center, Children's of Alabama, Cooper Green Hospital, and University of Alabama Hospital. He received his medical degree from Medical University of South Carolina College of Medicine and has been in practice 14 years. He specializes in central nervous system cancer, head & neck, and thoracic cancer.
Education & Training
Vanderbilt University Medical CenterResidency, Radiation Oncology, 2004 - 2008
Spartanburg Medical CenterInternship, Transitional Year, 2003 - 2004
Medical University of South CarolinaClass of 2003
Certifications & Licensure
AL State Medical License 2008 - 2025
SC State Medical License 2003 - 2004- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- A Study Evaluating an Advanced Pneumatic Compression Device Versus Usual Care for Treatment of Head and Neck Lymphedema Start of enrollment: 2021 Sep 23
Roles: Principal Investigator
Publications & Presentations
PubMed
- 40 citationsN-cadherin upregulation mediates adaptive radioresistance in glioblastoma.Satoru Osuka, Dan Zhu, Zhaobin Zhang, Chaoxi Li, Christian T. Stackhouse
The Journal of Clinical Investigation. 2021-03-15 - 18 citationsStable Phenotypic Changes of the Host T Cells Are Essential to the Long-Term Stability of Latent HIV-1 InfectionLillian Seu, Steffanie Sabbaj, Alexandra Duverger, Frederic Wagner, Joshua C. Anderson
Journal of Virology. 2015-07-01 - 100 citationsExpression signature of IFN/STAT1 signaling genes predicts poor survival outcome in glioblastoma multiforme in a subtype-specific manner.Christine W. Duarte, Christopher D. Willey, Degui Zhi, Xiangqin Cui, Jacqueline J. Harris
Plos One. 2012-01-05
Press Mentions
Melanoma Treatment: Potential Target Bypasses Therapeutic Resistance to Immune Checkpoint BlockersSeptember 16th, 2022- Drinking Even a Single Glass of Alcohol Can Trigger a Heart Condition, Study RevealsSeptember 18th, 2021
- UAB Researchers Identify Potential Therapeutic Target Against Malignant Brain TumorsApril 5th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
